Combating Parasitic Nematode Infections, Newly Discovered Antinematode Compounds from Marine Epiphytic Bacteria
Open Access
- 11 December 2020
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 8 (12) , 1963
Abstract
Parasitic nematode infections cause debilitating diseases and impede economic productivity. Antinematode chemotherapies are fundamental to modern medicine and are also important for industries including agriculture, aquaculture and animal health. However, the lack of suitable treatments for some diseases and the rise of nematode resistance to many available therapies necessitates the discovery and development of new drugs. Here, marine epiphytic bacteria represent a promising repository of newly discovered antinematode compounds. Epiphytic bacteria are ubiquitous on marine surfaces where they are under constant pressure of grazing by bacterivorous predators (e.g., protozoans and nematodes). Studies have shown that these bacteria have developed defense strategies to prevent grazers by producing toxic bioactive compounds. Although several active metabolites against nematodes have been identified from marine bacteria, drug discovery from marine microorganisms remains underexplored. In this review, we aim to provide further insight into the need and potential for marine epiphytic bacteria to become a new source of antinematode drugs. We discuss current and emerging strategies, including culture-independent high throughput screening and the utilization of Caenorhabditis elegans as a model target organism, which will be required to advance antinematode drug discovery and development from marine microbial sources.Keywords
This publication has 157 references indexed in Scilit:
- Impact of gastrointestinal parasitic nematodes of sheep, and the role of advanced molecular tools for exploring epidemiology and drug resistance - an Australian perspectiveParasites & Vectors, 2013
- Recent Advances in the Discovery and Development of Marine Microbial Natural ProductsMarine Drugs, 2013
- Assessing the Effectiveness of Functional Genetic Screens for the Identification of Bioactive MetabolitesMarine Drugs, 2012
- Bacterial Biosynthesis and Maturation of the Didemnin Anti-cancer AgentsJournal of the American Chemical Society, 2012
- Wide Distribution of Closely Related, Antibiotic-Producing Arthrobacter Strains throughout the Arctic OceanApplied and Environmental Microbiology, 2012
- Identification of Compounds with Bioactivity against the Nematode Caenorhabditis elegans by a Screen Based on the Functional Genomics of the Marine Bacterium Pseudoalteromonas tunicata D2Applied and Environmental Microbiology, 2010
- Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental ToxicologyToxicological Sciences, 2008
- The Sorcerer II Global Ocean Sampling Expedition: Northwest Atlantic through Eastern Tropical PacificPLOS Biology, 2007
- Developing a new resource for drug discovery: marine actinomycete bacteriaNature Chemical Biology, 2006
- Bioactive Microbial MetabolitesThe Journal of Antibiotics, 2005